ISI Advisory Board

George B. Stefano PhD., D.H.C. George B. Stefano PhD., D.H.C.

Besides serving International Scientific Information in the capacity of Editor-in Chief, Dr. Stefano is also the Deputy Editor of Medical Science Monitor Basic Research.  He is involved with development and growth decisions for ISI in the capacity of Vice President.  Additionally, he was a Distinguished Teaching Professor and CASE Professor of NY- at the State University of New York (SUNY).  He served for 11 years as Vice Chair and member of the Board of Directors of Research Foundation of SUNY and Vice Chair of its Executive Committee as well as Chair of its Research Committee.  He wrote over 470 peer reviewed reports, 7 books and over 51 chapters in texts.  He was funded by the NIH- Mental Health, and -Drug Abuse Institutes, National Science Foundation and various corporations.  He has served as Chief Science Officer of Mitogenetics, LLC and served on its Board of Directors.  He is the inventor of several licensed and commercialized patents, including those licensed by MitoGenetics.  He has been an organizer of both National and International meetings as well as workshops on Patents and Grantsmanship.  He is editor of several international journals as well serving on editorial boards.  He was a member of the  Mind Body Institute and Director of its Basic Research program at the Deaconess of Harvard Medical School.  He is also the  Recipient of numerous scientific and teaching awards.

Thomas Bilfinger, PhD Thomas Bilfinger, PhD

Dr. Thomas Bilfinger is a Professor of Cardiothoracic Surgery at Stony Brook University Hospital. His practice encompasses both heart and lung surgery. He provides consultation and surgical care for adult patients with advanced forms of heart disease and also for patients with a range of benign and malignant pulmonary diseases. His practice uses the most sophisticated conventional procedures, as well as the new minimally invasive procedures, including thoracic aortic stenting for aneurysms and radiofrequency and cryoablation for lung tumors. He is the founding member and Director of the multidisciplinary Lung Cancer Evaluation Center for the past fifteen years.Dr. Bilfinger has more than 130 publications to his credit, most of which are in peer-reviewed journals. He's a Fellow of the American College of Surgeons (FACS), Fellow of the American College of Cardiology (FACC), Fellow of the College of Chest Physicians (FCCP), and Fellow of the American Heart Association (FAHA). Dr. Bilfinger has been selected for inclusion in the Castle Connolly Guide, Top Doctors: New York Metro Area, as well as in the “Best Doctors” listing of New York Magazine, representing the top 2% of physicians in the New York Metropolitan area. 

 

Fuzhou Wang, MD, PhD Fuzhou Wang, MD, PhD

Dr. Wang obtained his MD degree from Southeast University in China in 2003 and finished his anesthesiology fellowship training as well as his PhD study in biology in Nanjing University in 2011. In 2013, he completed his research associate at Wake Forest University Baptist Health. Dr. Wang now holds the director position and senior research scientist in the Neurobiological & Neurophysiological division of The BASE and associate professor of Nanjing Medical University. Dr. Wang’s research interests are molecular and epigenetic mechanisms of chronic pain, learning and memory defection from anesthesia and Alzheimer’s disease, and novel molecule innovation for relieving pain and defending memory loss. Dr. Wang functions as Editors-in-Chief for two internationalized journals: Medical Science Monitor Basic Research and Science INSIGHTS®, and Editorial Board member of World Journal of Anesthesiology, World Journal of Meta-Analysis, and Asian Case Report-Critical Care Medicine. He has over 70 publications in peer-reviewed journals and 4 licensed patents.

Richard M. Kream, Ph.D. Richard M. Kream, Ph.D.

Dr. Richard M. Kream earned his Ph.D. in Biochemistry from Albert Einstein School of Medicine. He was a Professor of Anesthesiology and Pharmacology at Tufts University Medical School until 2000. He was then Professor of Biochemistry at SUNY Downstate before joining the Neuroscience Research Institute at the SUNY Old Westbury as a recipient of an Empire Innovation Program faculty appointment. He has published over 140 reports and has numerous patent pending applications, which are being commercialized. He is on the Editorial Board of several international journals and was instrumental in establishing Medical Science Monitor Basic Research.  His field of expertise involves non-addicting analgesics and novel opioid compounds and their involvement in energy processes. He also served as Assistant Vice President for Research at Mitogenetics, LLC.  He is the founder of and chief scientific officer of Chimeracom LLC.

Tobias Esch, MD Tobias Esch, MD

Tobias Esch (MD) is a primary care physician and tenured Professor of Integrative Health Care at Witten/Herdecke University, Germany, School of Medicine. He also serves as acting vice-dean/Dean for Organisational Development of the Faculty of Health. As a 2013-14 Harkness Fellow in Health Care Policy and Practice (Commonwealth Fund, New York) and Visiting Professor of Medicine at Harvard Medical School (Beth Israel Deaconess Medical Center, Division of General Practice and Primary Care) he has studied patient engagement and self-regulation with a particular focus on subjects with high disease burden; currently, he is initiating multidisciplinary research on transparency in patient-clinician interaction. With an additional background in neuroscience and especially the brain’s reward and motivation circuitries, including applications derived in mind/body and integrative medicine, he has (co-)authored over 200 scientific publications, 50 book chapters and monographies, and won numerous awards.